Target intelligence / Profile preview

Zinc finger protein 683 (ZNF683)

Target
ZNF683
Molecular classification
Transcription factor, Zinc finger protein
01

Overview

Zinc finger protein 683 (ZNF683), also known as Hobit, is a transcription factor predominantly expressed in tissue-resident T cells, natural killer (NK) cells, and certain other lymphocyte populations. ZNF683 acts as a master regulator of tissue residency in immune cells by suppressing the expression of genes involved in cell egress from non-lymphoid tissues, thereby promoting the long-term establishment and maintenance of adaptive and innate tissue-resident lymphocyte subsets in organs like the skin, gut, liver, and kidney. It also plays a key role in the differentiation of NK and NKT cells and modulates cytokine production, including inhibiting interferon-gamma (IFN-γ) expression under certain conditions. ZNF683 is homologous to the transcriptional repressor BLIMP1/PRDM1, but unlike BLIMP1, it specializes in governing resident immunity rather than inducing terminal differentiation. Its activity is critical for the rapid local responses to infection or reinfection at tissue sites. To date, ZNF683 is not known to be directly targeted by any drugs, nor is it a routinely used biomarker or an established cause of safety concerns in therapeutic development.

Other names
HobitTissue-resident T-cell transcription regulator protein ZNF683MGC33414Homolog of Blimp-1 in T-cellHomolog of Blimp-1 in T cellsHypothetical protein MGC33414
02

Mechanism of action

Not applicable; no direct drug interactions described

03

Biological functions

Regulation of gene expressionRegulation of lymphocyte differentiationControl of tissue residency in immune cellsNegative regulation of tissue egress in T cellsNegative regulation of interferon-gamma (IFN-γ) production
04

Disease associations

Infection (protective tissue immunity)Possibly cancer (as a regulator of tissue-resident immune cells in the tumor microenvironment)Immune response modulation (autoimmunity/inflammation context not yet fully established)
05

Safety considerations

Not established, as this is not a direct therapeutic target or drug-related protein
06

Interacting drugs

None known
07

Biomarkers

None established for clinical patient selection or monitoring

Beyond the preview

Go deeper on Zinc finger protein 683 (ZNF683).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 683 (ZNF683).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call